Expert Interview
A look at FDA approved BIMZELX® (bimekizumab) for moderate to severe plaque psoriasis patients who are candidates for systemic therapy or phototherapy.
Ticker(s): UCBInstitution: NE Dermatology
HAS PRESCRIED ADBRY
Dr. Stephanie Cotell graduated Cum Laude from Duke University and attended medical school at Northwestern University, graduating in the Alpha Omega Honor Society. She completed her internship and residency in Dermatology at Northwestern University. She has been published in national medical journals including the New England Journal of Medicine, Archives of Internal Medicine, International Journal of Dermatology, American Journal of Emergency Medicine, and the Journal of Investigative Dermatology.
Interviewed regularly for her skincare expertise, Dr. Cotell has appeared on Good Day Columbus and her most recent interview was in City Scene Magazine in December 2019. She lectures throughout the country on topics such as atopic dermatitis, psoriasis, rosacea, acne, and other conditions. Dr. Cotell emphasizes a comprehensive approach to skincare, including skin cancer screening, and counsels patients on how to attain and maintain healthy skin.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
